BioNote Inc
KRX:377740
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3 985
6 080
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
BioNote Inc
| Current Assets | 467.1B |
| Cash & Short-Term Investments | 416.7B |
| Receivables | 22.9B |
| Other Current Assets | 27.5B |
| Non-Current Assets | 1.2T |
| Long-Term Investments | 1.1T |
| PP&E | 90.3B |
| Intangibles | 9.7B |
| Other Non-Current Assets | 1.8B |
| Current Liabilities | 18B |
| Accounts Payable | 3.3B |
| Accrued Liabilities | 1.5B |
| Other Current Liabilities | 13.3B |
| Non-Current Liabilities | 32B |
| Long-Term Debt | 2.7B |
| Other Non-Current Liabilities | 29.3B |
Balance Sheet
BioNote Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
6 576
|
123 080
|
418 612
|
681 067
|
147 395
|
|
| Cash |
0
|
0
|
0
|
0
|
15 453
|
|
| Cash Equivalents |
6 576
|
123 080
|
418 612
|
681 067
|
131 942
|
|
| Short-Term Investments |
1 147
|
80 531
|
70 000
|
39 722
|
252 590
|
|
| Total Receivables |
8 825
|
310 664
|
84 079
|
18 304
|
24 864
|
|
| Accounts Receivables |
8 825
|
310 577
|
83 961
|
17 821
|
23 964
|
|
| Other Receivables |
0
|
87
|
118
|
483
|
901
|
|
| Inventory |
7 757
|
53 053
|
64 859
|
79 038
|
30 683
|
|
| Other Current Assets |
333
|
6 100
|
3 159
|
6 705
|
945
|
|
| Total Current Assets |
24 638
|
573 428
|
640 709
|
824 836
|
456 478
|
|
| PP&E Net |
23 577
|
49 659
|
98 007
|
97 159
|
89 594
|
|
| PP&E Gross |
0
|
49 659
|
98 007
|
97 159
|
89 594
|
|
| Accumulated Depreciation |
0
|
8 515
|
12 199
|
17 363
|
31 473
|
|
| Intangible Assets |
305
|
250
|
354
|
1 589
|
4 750
|
|
| Goodwill |
0
|
0
|
5 512
|
5 512
|
5 512
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
942
|
|
| Long-Term Investments |
82 311
|
229 701
|
743 863
|
827 748
|
1 035 075
|
|
| Other Long-Term Assets |
0
|
401
|
422
|
157
|
491
|
|
| Other Assets |
0
|
0
|
5 512
|
5 512
|
5 512
|
|
| Total Assets |
130 831
N/A
|
853 440
+552%
|
1 488 867
+74%
|
1 757 002
+18%
|
1 592 842
-9%
|
|
| Liabilities | ||||||
| Accounts Payable |
2 316
|
29 670
|
5 412
|
3 302
|
3 520
|
|
| Accrued Liabilities |
0
|
10 936
|
10 034
|
5 199
|
1 999
|
|
| Short-Term Debt |
12 000
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
42
|
138
|
296
|
469
|
1 334
|
|
| Other Current Liabilities |
2 526
|
143 168
|
102 530
|
40 536
|
3 947
|
|
| Total Current Liabilities |
16 883
|
183 912
|
118 273
|
49 505
|
10 801
|
|
| Long-Term Debt |
50
|
207
|
474
|
893
|
3 594
|
|
| Deferred Income Tax |
3 291
|
30 593
|
97 517
|
106 300
|
21 652
|
|
| Other Liabilities |
30
|
32
|
99
|
151
|
219
|
|
| Total Liabilities |
20 255
N/A
|
214 744
+960%
|
216 363
+1%
|
156 850
-28%
|
36 266
-77%
|
|
| Equity | ||||||
| Common Stock |
2 924
|
2 924
|
46 778
|
50 938
|
51 028
|
|
| Retained Earnings |
51 991
|
580 217
|
1 207 900
|
1 466 034
|
1 392 828
|
|
| Additional Paid In Capital |
55 732
|
55 732
|
11 877
|
80 997
|
82 744
|
|
| Other Equity |
69
|
176
|
5 948
|
2 183
|
29 976
|
|
| Total Equity |
110 577
N/A
|
638 696
+478%
|
1 272 504
+99%
|
1 600 152
+26%
|
1 556 576
-3%
|
|
| Total Liabilities & Equity |
130 831
N/A
|
853 440
+552%
|
1 488 867
+74%
|
1 757 002
+18%
|
1 592 842
-9%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
102
|
102
|
102
|
102
|
102
|
|
You don't have any saved screeners yet
